Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA modification in the tumor immune microenvironment: novel implications for immunotherapy. Front Immunol. 2021;12:773570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Ma S, Deng Y, Yi P, Yu J. Targeting the RNA m(6)A modification for cancer immunotherapy. Mol Cancer. 2022;21:76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12:121.

Article  PubMed  PubMed Central  Google Scholar 

Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Liu F, Chen W, Liao Z, Zhang W, Zhang B, et al. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy. Exp Hematol Oncol. 2022;11:30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun X, Fu S, Yuan X, Pu X, Wang R, Wang X, et al. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential. Cancer Gene Ther. 2023;30:1209–14.

Article  CAS  PubMed  Google Scholar 

An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng S, Han H, Lin S. N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity. Cancer Biol Med. 2022;19:385–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du Y, Ma Y, Zhu Q, Liu T, Jiao Y, Yuan P, et al. An m6A-related prognostic biomarker associated with the hepatocellular carcinoma immune microenvironment. Front Pharm. 2021;12:707930.

Article  CAS  Google Scholar 

Hu C, Liu J, Li Y, Jiang W, Ji D, Liu W, et al. Multifaceted roles of the N(6)-methyladenosine RNA methyltransferase METTL3 in cancer and immune microenvironment. Biomolecules. 2022;12:1042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Xiao P, Tang J, Wang R, Wang X, Wang F, et al. m6A regulator-mediated tumour infiltration and methylation modification in cervical cancer microenvironment. Front Immunol. 2022;13:888650.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19:44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhuang H, Yu B, Tao D, Xu X, Xu Y, Wang J, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22:91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18:103.

Article  PubMed  PubMed Central  Google Scholar 

Quan C, Belaydi O, Hu J, Li H, Yu A, Liu P, et al. N(6)-Methyladenosine in cancer immunotherapy: an undervalued therapeutic target. Front Immunol. 2021;12:697026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng LJ, Deng WQ, Fan SR, Chen MF, Qi M, Lyu WY, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022;21:52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.

Article  PubMed  PubMed Central  Google Scholar 

Xu Y, Song M, Hong Z, Chen W, Zhang Q, Zhou J, et al. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. J Exp Clin Cancer Res. 2023;42:10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898.

Article  PubMed  PubMed Central  Google Scholar 

Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oerum S, Meynier V, Catala M, Tisne C. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49:7239–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79–96.e11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z, et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021;33:1221–33.e11.

Article  CAS  PubMed  Google Scholar 

Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Chai G, Wu Y, Li J, Chen F, Liu J, et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat Commun. 2019;10:2065.

Article  PubMed  PubMed Central  Google Scholar 

Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48:3816–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Liu J, Guo H, Hong D, Ji J, Zhang Q, et al. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered. 2021;12:3159–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer. 2022;21:32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Yang Z, Li R, Wu Y, Chi M, Gao S, et al. Potential roles of N6-methyladenosine (m6A) in immune cells. J Transl Med. 2021;19:251.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS, et al. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. J Exp Med. 2021;218:e20210279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YG, Chen R, Ahmad S, Verma R, Kasturi SP, Amaya L, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76:96–109.e9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Zhao Y, Zou L, Zhang D, Aki D, Liu Y-C. The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control. J Exp Med. 2019;216:1664–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lou X, Wang J-J, Wei Y-Q, Sun J-J. Emerging role of RNA modification N6-methyladenosine in immune evasion. Cell Death Dis. 2021;12:300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Zhang X, Su H, Zeng J, Chan H, Li Q, et al. Immune dysregulation and RNA N6-methyladenosine modification in sepsis. Wiley Interdiscip Rev RNA. 2023;14:e1764.

Article  CAS  PubMed